Ask Warren

Medy-Tox

086900 · KOSDAQ · ₩086900 · 메디톡스

₩63,900▼ ₩300 (0.47%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩69B₩61B₩61B₩61B₩62B₩64B₩55B₩54B
Cost of sales₩28B₩19B₩24B₩25B₩29B₩26B₩22B₩22B
Gross profit₩41B₩42B₩36B₩36B₩33B₩38B₩33B₩31B
Operating income₩4.8B₩7.4B−₩3.7B₩8.9B₩6.3B₩5.5B₩947M₩6B
Net income−₩4.8B₩7.9B₩8.5B−₩975M₩4.8B₩3.3B₩12B−₩7.6B
Net income to shareholders₩3.1B₩7.8B−₩3B₩7.4B₩8.4B₩3.8B₩3.2B₩3.8B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩572B₩565B₩582B₩587B₩581B₩603B₩615B₩625B
Current assets₩158B₩146B₩155B₩171B₩159B₩176B₩187B₩161B
Cash and equivalents₩47B₩42B₩49B₩59B₩45B₩52B₩46B₩28B
Total liabilities₩193B₩185B₩127B₩119B₩116B₩139B₩144B₩127B
Current liabilities₩153B₩145B₩105B₩96B₩88B₩112B₩118B₩119B
Borrowings₩123B₩123B₩75B₩75B₩75B₩75B₩79B₩83B
Total equity₩379B₩380B₩454B₩468B₩465B₩465B₩471B₩499B
Shareholders' equity₩374B₩375B₩452B₩465B₩462B₩462B₩466B₩493B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩9.2B₩24B₩16B₩19B₩9.8B₩17B₩16B₩12B
Capital spending₩1.6B₩1.7B₩9B₩1.7B₩2.3B₩2.7B₩956M₩2.2B
Free cash flow₩7.6B₩23B₩6.8B₩17B₩7.4B₩14B₩15B₩10B
Dividends paid——————₩8.4B₩0

Consolidated where available. Amounts in won.

Also known as: Medy-Tox / 메디톡스 / 086900 / KRX:086900

Source: KRX statistical information